| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.394 | 16.172 | 22.501 | 16.223 | 28.166 | 31.170 | 33.857 | 136.202 |
| Total Income - EUR | - | - | 6.394 | 16.172 | 22.574 | 16.223 | 28.166 | 31.170 | 33.857 | 136.202 |
| Total Expenses - EUR | - | - | 4.437 | 6.346 | 7.458 | 7.897 | 8.598 | 10.574 | 11.488 | 21.248 |
| Gross Profit/Loss - EUR | - | - | 1.957 | 9.826 | 15.116 | 8.326 | 19.568 | 20.596 | 22.369 | 114.954 |
| Net Profit/Loss - EUR | - | - | 1.893 | 9.664 | 14.891 | 8.174 | 19.292 | 20.290 | 22.037 | 110.950 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermpat Expert Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 7.335 | 6.205 | 5.254 | 4.271 | 8.002 |
| Current Assets | - | - | 2.529 | 10.459 | 15.833 | 1.746 | 14.292 | 16.341 | 19.430 | 136.668 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 397 | 0 | 0 | 0 | 0 | 0 | 0 | 110.950 |
| Cash | - | - | 2.132 | 10.459 | 15.833 | 1.746 | 14.292 | 16.341 | 19.430 | 25.718 |
| Shareholders Funds | - | - | 1.937 | 9.716 | 14.941 | 8.224 | 19.341 | 20.339 | 22.086 | 110.998 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 592 | 744 | 892 | 857 | 1.156 | 1.257 | 1.616 | 33.672 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermpat Expert Diagnostic Srl